AMEX · FESM
Fidelity Enhanced Small Cap ETF
$45.47-$0.78 (-1.69%)
Fidelity Enhanced Small Cap ETF’s quoted price sits in the upper half of its reported 52-week range, 7.07% below the high.
Loading market information…
NASDAQ · PRFZ · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Invesco RAFI US 1500 Small-Mid ETF’s quoted price sits in the upper half of its reported 52-week range, 6.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Invesco RAFI US 1500 Small-Mid ETF’s forward annual dividend is $0.52 per share, paid quarterly. The forward yield is 0.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Invesco RAFI US 1500 Small-Mid ETF (PRFZ) aims to replicate the performance of the RAFI Fundamental Select US 1500 Index. Typically, the Fund allocates at least 90% of its total assets to the common stocks that make up this index. The underlying index focuses on tracking the performance of small and medium-sized U.S. companies. Its constituent firms are chosen based on four core financial indicators: book value, cash flow generation, sales revenue, and dividend payments. Specifically, the index selects equities ranked between 1,001 and 2,500 in fundamental size from a universe of 3,000 companies, assigning each a weight proportional to its fundamental value. Both the ETF's portfolio and the index's composition undergo annual rebalancing. A significant shift is scheduled for the close of business on March 21, 2025. The Fund will transition from its current benchmark, the FTSE RAFI US 1500 Mid Small Index, to the RAFI Fundamental Select US 1500 Index. Concurrently, the Fund's official name will be "Invesco RAFI US 1500 Small-Mid ETF." As of August 31, 2025, Morningstar Inc. awarded the Fund an overall 4-star rating, placing it favorably among 577 evaluated funds. This strong performance was consistent across various durations: it earned 4 stars for the 3-year period (out of 577 funds), 4 stars for the 5-year period (out of 556 funds), and 4 stars for the 10-year period (out of 405 funds). Morningstar's ratings employ a risk-adjusted return methodology, which considers monthly performance fluctuations, emphasizing penalties for downward volatility and rewarding consistent returns. For comparative analysis, Morningstar integrates open-end mutual funds and exchange-traded funds into a single comparison group. Only funds with a minimum of three years of operational history are eligible for ratings. The comprehensive overall rating is a weighted average derived from the 3-, 5-, and 10-year performance metrics, where applicable, and includes all fees and expenses but excludes sales charges. Important Disclaimers from Morningstar: This information is proprietary and must not be copied or distributed. Morningstar does not guarantee its accuracy, completeness, or timeliness, nor do they assume responsibility for any damages or losses resulting from its use. Investors should be aware that past performance is not a reliable indicator of future results. Within each category, the top 10% of funds receive five stars, the subsequent 22.5% earn four stars, the middle 35% are awarded three stars, the next 22.5% get two stars, and the bottom 10% receive one star. These ratings are subject to monthly updates. It is also important to note that any fee waivers or expense reimbursements, current or past, might have positively impacted the Morningstar rating, which could have been lower otherwise. Furthermore, ratings for different share classes may vary due to distinct performance characteristics.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 06:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
KEEP COMPARING
$45.47-$0.78 (-1.69%)
Fidelity Enhanced Small Cap ETF’s quoted price sits in the upper half of its reported 52-week range, 7.07% below the high.
$43.56-$0.51 (-1.16%)
GMO US Quality ETF’s quoted price sits in the upper half of its reported 52-week range, 1.83% below the high.
$85.29-$1.44 (-1.66%)
iShares U.S. Small-Cap Equity Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 6.01% below the high.
$41.19-$0.41 (-0.99%)
iShares International Equity Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 5.29% below the high.
$42.94-$0.38 (-0.88%)
Fidelity Enhanced Large Cap Value ETF ’s quoted price sits in the upper half of its reported 52-week range, 0.88% below the high.
$96.19-$1.29 (-1.32%)
iShares Core 80/20 Aggressive Allocation ETF’s quoted price sits in the upper half of its reported 52-week range, 3.84% below the high.
$93.45-$0.42 (-0.45%)
State Street SPDR S&P 400 Mid Cap Value ETF’s quoted price sits in the upper half of its reported 52-week range, 4.23% below the high.
$102.87-$2.03 (-1.94%)
State Street SPDR S&P 400 Mid Cap Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 9.71% below the high.
